Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: ProteoMetrics in Acquisition Talks with Genomic Solutions

NEW YORK, July 30 - ProteoMetrics said Monday that it is currently in acquisition talks with Genomic Solutions.

"We're exploring a number of different business opportunities and an acquisition is one of them," said Jennifer Krone, vice president of scientific services at ProteoMetrics.

Under the terms of the agreement,  Genomic Solutions of Ann Arbor, Mich., has a first right of refusal to acquire New York-based Proteometrics, the companies said in a joint statement. Krone said ProteoMetrics has entered a 60-day quiet period during which it may not discuss other acquisitions but can go forward with other original equipment manufacturer deals.

Genomic Solutions was not available for comment.

The two companies announced earlier in the day that they plan to jointly develop a software product that merges Genomic Solutions’ Investigator Protein Warehouse data integration software with ProteoMetrics’ Radars mass spectrometry analysis system.

Genomic Solutions will also market ProteoMetrics' Knexus, Profound, and Sonar MS/MS software products. 

Krone declined to comment on whether Genomic Solutions had made an equity investment in ProteoMetrics.

Jeffrey Williams, CEO of Genomic Solutions, said in a statement that the partnership "will bring powerful new features and advantages to our existing Protein Warehouse software and enhance integration of our total Investigator Proteomic System with mass spectrometers from the leading vendors." 

This is the second bioinformatics partnership Genomic Solutions has entered recently. On July 19, the company said it was working with Atlanta-based NuTec Sciences to develop microarray analysis software for its GeneTac microarray system.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.